The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.
LONDON, England—New research has identified several high-risk variables associated with the need for a new permanent pacemaker after TAVI for aortic stenosis. None on the list are among the more ...
This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results